• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PYS
Click for more information
0.00% 23.0¢

PaySauce Limited Ordinary Shares

watchlist Created with Sketch. Add to my watchlist
Industrials

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PYS
Ann: 2024 Annual Meeting Results 		19/09/24 0 24
19/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  24 
PYS
Ann: 2024 Annual Meeting Addresses and Presentation 		19/09/24 0 22
19/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  22 
PYS
Ann: PaySauce Senior Management changes 		18/09/24 0 37
18/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  37 
PYS
Ann: Notice of Annual Meeting 		13:47 0 78
13:47 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  78 
PYS
Ann: Annual Meeting and Director Nominations 		07/08/24 0 40
07/08/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  40 
PYS
Ann: D&O Ongoing Disclosures - Director 		24/07/24 0 83
24/07/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  83 
PYS
Ann: D&O Ongoing Disclosures - CEO, CTO, COO, CFO and Director 		09:20 0 86
09:20 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  86 
PYS
Ann: Capital Change Notice - Employee Share Scheme (F25 Q1) 		19/07/24 0 76
19/07/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  76 

See All Discussions arrow Created with Sketch.

Featured News

NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
(20min delay)
Last
23.0¢ 		Change
0.000(0.00%) 		Mkt cap ! n/a
Open High Low Value Volume
23.0¢ 23.0¢ 23.0¢ $22 95

Buyers (Bids)

No. Vol. Price($)
0 20697 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 32000 0
Last trade - 05.59am 20/09/2024 (20 minute delay) ?
PYS (NZSX) Chart

Top Stories

Sandfire's latest drill run extends known polymetal mineralisation at the Sesmarias Prospect

Sandfire Limited (ASX:SFR) has posted evidence of extended mineralisation at its Portugese Sesmarias Prospect.
Firetail executive changes set to propel development in Canada and Peru Firetail Resources Ltd has appointed former CEO Glenn Poole as managing director, while Brett Grosvenor has stepped into a non-executive role
Catalina Resources kicks off aircore drilling at Laverton project on the hunt for gold, REEs Catalina Resources has confirmed its latest drill run has kicked off on-site its Laverton Project in Western Australia's Northern Goldfields.
Week 38 Wrap: US markets panic at 50bp cut; ALS’s minerals revenue  slowdown; RBA path unclear Well, it finally happened – the US Fed cut interest rates this week, and we got a double dose: a whole -50bps knocked off.
Tennant Minerals clocks high-grade gold, copper hits at Bluebird in the NT Tennant Minerals has unveiled the results of its latest drill campaign at its Bluebird project, posting "high-grade" copper and gold hits.

Featured News

EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.